These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30464609)

  • 61. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway.
    Meng Q; Xue H
    Technol Cancer Res Treat; 2020; 19():1533033820905823. PubMed ID: 32233835
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Down-regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs.
    Zhang X; Liu J; Gu Y; Sun C; Qu F
    Cell Biol Int; 2019 Feb; 43(2):158-166. PubMed ID: 30536541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway].
    Chu ZH; Liang XH; Zhou XL; Huang RF; Zhan Qz; Jiang JW
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):533-8. PubMed ID: 21565140
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling.
    Yin Y; Wang X; Li T; Ren Q; Li L; Sun X; Zhang B; Wang X; Han H; He Y; Cao Z; Sun X; Zhou Z
    Cancer Med; 2020 Feb; 9(4):1544-1552. PubMed ID: 31899608
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
    Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
    Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
    Li G; Xu D; Sun J; Zhao S; Zheng D
    Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oncogenic role of LYN in human gastric cancer via the Wnt/β-catenin and AKT/mTOR pathways.
    Su R; Zhang J
    Exp Ther Med; 2020 Jul; 20(1):646-654. PubMed ID: 32509024
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
    Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
    Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.
    Nguyen Hoang AT; Hoe KL; Lee SJ
    PLoS One; 2021; 16(4):e0246264. PubMed ID: 33861751
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
    Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
    BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
    Xu B; Zhou M; Qiu W; Ye J; Feng Q
    Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
    Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
    Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway.
    Wang Y; Shen SY; Liu L; Zhang XD; Liu DY; Liu N; Liu BH; Shen L
    J Ethnopharmacol; 2022 Jan; 282():114581. PubMed ID: 34464697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Mechanism of Adaptation of Breast Cancer Cells to Hypoxia: Role of AMPK/mTOR Signaling Pathway.
    Sorokin DV; Scherbakov AM; Yakushina IA; Semina SE; Gudkova MV; Krasil'nikov MA
    Bull Exp Biol Med; 2016 Feb; 160(4):555-9. PubMed ID: 26902354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
    Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
    Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.